ISCHAEMIC HEART DISEASE Acute Coronary Syndromes JD Marx Department of Cardiology University of the Free State.

Slides:



Advertisements
Similar presentations
PBL CV 2 Pathophysiology of coronary artery disease.
Advertisements

Update on the Medical Management of Acute Coronary Syndrome.
Anti-platelet drugs Dr. Ishfaq Bukhari Dec
British Cardiac Intervention Society Risk Assessment In Acute Coronary Syndromes Dr David Newby BHF Senior Lecturer in Cardiology Associate Director of.
Chronic stable angina Dr Taban Internist & cardiologist.
Antiplatelet Drugs (Anti-thrombotics)
1.  Atherosclerosis is most common cause of coronary artery disease (CAD).  Atherosclerosis can affect one or all three major coronary arteries i.e.
Ischemic heart disease
Ischemic Heart Diseases IHD
Dr. Ishfaq Bukhari.  In healthy vasculature, circulating platelets are maintained in an inactive state by nitric oxide (NO) and prostacyclinre (PGI2)leased.
Update on the Medical Management of Acute Coronary Syndrome.
Guidelines on Perioperative Cardiovascular Evaluation and Care for Noncardiac Surgery 2007 ACC/AHA and 2009 ESC GUIDELINES.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
Coronary Artery Disease Angina Pectoris Unstable Angina Variant Angina Joseph D. Lynch, MD.
Ischemic heart disease. Indications and methods of surgical treatment. Surgery department №2.
Call for CASES Leszek D. Stachaczyk, MD Pawel Buszman, MD, FESC, FSCAI American Heart of Poland, Ustroñ, Poland & CCU, Upper-Silesian Center of Cardiology,
Pt assigned to CABG is in yellow Pt assigned to PTCA is in blue Diabetics benefited from CABG than from PTCA alone, evidenced by 75% 6year survivabilit.
1.  Atherosclerosis is most common cause of coronary artery disease (CAD).  Atherosclerosis can affect one or all three major coronary arteries i.e.
Antiplatelet Drugs - Principles Benedict R. Lucchesi, M.D., Ph.D. Department of Pharmacology University of Michigan Medical School.
Ticlopidine (Ticlid™) and Clopidogrel (Plavix™) Benedict R. Lucchesi, M.D., Ph.D. Department of Pharmacology University of Michigan Medical School.
Management of Coronary Artery Disease
Atherosclerosis Part 1 Atherosclerosis The general term for hardening of the arteries The most prevalent form of atherosclerosis is characterized by the.
Ischemic heart disease Basic Science 3/15/06. All of the following concerning coronary artery anatomy are correct except: The left main coronary artery.
VULNERABLE PLAQUES: Pertinent doubts and solutions in interventional cardiology EuroPCR Paris, 16 May 2006.
2. Ischaemic Heart Disease.
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
Cause : lipid rich plaque; calcified coronary lesion Location of vessel : native coronary artery; renal artery Laterality : Left; Right; bilateral Specificity,
Elsevier items and derived items © 2006 by Elsevier Inc. Coronary Artery Disease Includes stable angina pectoris and acute coronary syndromes Ischemia:
Ischaemic Heart Disease. Aims and Objectives n Ischaemic heart disease –Definition, manifestations, epidemiology, aetiology, pathophysiology, risk factors.
ANTIPLATELET DRUGS.
Department faculty and hospital therapy of medical faculty and department internal diseases of medical prophylactic faculty. MYOCARDIAL INFARCTION Prof.
ASPIRIN ↓ Cox inhibition ↓ (PROSTACYCLIN) PGI 2 & TXA 2 (THROMBOXANE) LOW DOSE ASPIRIN.
ANTIPLATELET DRUGS Learning objectives By the end of this lecture, students should be able to: - describe different classes of anti-platelet drugs and.
What’s new in Acute Coronary Syndrome 2005?
Unit 6 Seminar Chapter 10 HS 200: Diseases of the Human Body Dr. Allan Ayella.
ANTIPLATELETES AGENTS BY :DR. ISRAA OMAR. The role of platelets Platelets play a critical role in thromboembolic disease like ischemic heart disease and.
ANTIPLATELETES AGENTS
Acute Coronary Syndromes
Antiplatelet drugs Prof. Hanan Hagar Learning objectives By the end of this lecture, students should be able to to describe different classes of anti-platelet.
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
Acute Coronary Syndromes in West Hertfordshire Masood Khan.
 Heart disease remains the leading cause of morbidity and mortality in industrialized nations.  40% of all deaths in the U.S.A (nearly twice the number.
Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.
Ischemic Heart Disease CVS3 Hisham Alkhalidi. Ischemic Heart Disease A group of related syndromes resulting from myocardial ischemia.
Antiplatelet drugs Prof. Hanan Hagar Learning objectives By the end of this lecture, students should be able to To describe the role of platelets in.
Prof. Abdulrahman Almotrefi
 Coronary artery disease (also called CAD) is the most common type of heart disease. It is also the leading cause of death for both men and women in.
Myocardial Infarction (MI) Prepared by Miss Fatima Hirzallah RNS, MSN,CNS.
End points in PTCA trials. A successful angioplasty is defined as the reduction of a minimum stenosis diameter to
Date of download: 9/17/2016 Copyright © The American College of Cardiology. All rights reserved. From: 2014 AHA/ACC Guideline for the Management of Patients.
Ischaemic heart disease. Coronary artery disease(CAD) is the leading cause of death worldwide. The rates of mortality and disability due to CAD are increasing.
Lesson 11.2 congenital heart disease (CHF) Atherosclerosis
Ischemic Heart Disease
CORONARY ARTERY DISEASE
Ischaemic Heart Disease Acute Coronary Syndrome
Oral Anticoagulation and Preventing Stent Thrombosis
R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R
Glenn N. Levine et al. JACC 2016;68:
Nursing Management: Patients With Coronary Vascular Disorders
Coronary Artery Disease and Acute Coronary Syndrome
Glenn N. Levine et al. JACC 2016;68:
Chapter 28 Management of Patients With Coronary Vascular Disorders
Coronary Artery Disease and Acute Coronary Syndrome
Update on the New Antiplatelet Agents:
Prof. Abdulrahman Almotrefi
Antiplatelet Drugs Dr. : Asmaa Fady MD., MSC, M.B, B.Ch
R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R
P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.
Cardiovascular Epidemiology and Epidemiological Modelling
Presentation transcript:

ISCHAEMIC HEART DISEASE Acute Coronary Syndromes JD Marx Department of Cardiology University of the Free State

Acute Coronary Syndromes PATHOPHYSIOLOGY  Intermittent, partial or total occlusion of coronary artery responsible for acute myocardial ischaemia  Several factors play a role

Acute Coronary Syndromes PATHOPHYSIOLOGY Unstable angina MI Ischemic stroke/TIA Critical leg ischemia Intermittent claudication CV death Atherosclerosis Stable angina intermittent claudication Thrombosis MI=myocardial infarction ACS=acute coronary syndromes TIA=transient ischemic attack CV=cardiovascular ACS

Acute Coronary Syndromes  Vulnerable plaque present in most patients  Culprit lesions most often a low grade lesion 1. Atherosclerotic Lesions in ACS

Acute Coronary Syndromes Multiple Unstable Lesions

Acute Coronary Syndromes T LYMPHOCYTES 7% 25% 29% 6% 29% 43% RECURRENT UAP 2. Inflammation in ACS

Acute Coronary Syndromes  Thrombosis on ulcerated or ruptured plaque plays pivotal role › Platelet Thrombus › Fibrin Thrombus 3. Thrombus in ACS

Platelet Adhesion Tissue factor, vWF COLLAGEN I GP lb- IX GP IIb - IIIa GP Ia - IIa Plaque rupture, endothelial damage, fibrous cap erosion

Platelet Activation and Aggregation Platelet Thrombin ADP Thromboxane A 2 Epinephrine Serotonin Collagen PAR-1 PAR-4 P2Y 1 P2Y 12 TXA2-R 5HT 2 A Anionic phospholipid surfaces GP IIb GP IIIa GP VI Platelet GP IIIa GP IIb Fibrinogen GP Ia

Platelet Aggregation Flowing disc- shaped platelet Rolling ball-shaped platelet Hemisphere- shaped platelet Spreading platelet FIRM, BUT REVERSIBLE ADHESION IRREVERSIBLE ADHESION Scanning electron micrograph of discoid, dormant platelets Activated, aggregating platelets illustrating fibrin strands

Platelet Thrombus

Thrombus on Plaque Rupture

Microembolization in Unstable Angina Courtesy of C. Michael Gibson, MS, MD, Director TIMI Data Coordinating Center, Brigham & Women’s Hospital, Associate Chief of Cardiology, Interventional Cardiologist, Beth Israel Deaconess Medical Center, Harvard Medical School.

Acute Coronary Syndromes  Thrombosis on ulcerated or ruptured plaque plays pivotal role › Platelet Thrombus › Fibrin Thrombus 3. Thrombus in ACS

Fibrin Thrombus

Can play an important etiological role Acute Coronary Syndromes 4. Coronary Artery Spasm in ACS

Acute Coronary Syndromes PATIENT WITH MYOCARDIUM AT RISK CLINICAL PRESENTATION  Unstable Angina Pectoris › Angina of recent onset ( 1 month ) › Angina at rest › Worsening angina › Early post infarction angina  Non ST-segment elevation myocardial infarction › Cardiac enzymes elevated e.g. troponins,CK, MB-CK  ST-segment elevation myocardial infarction › Normal progression to Q-wave infarction

Acute Coronary Syndromes Unstable Angina Pectoris & Non ST-segment elevation infarction TREATMENT 1.Medical Stabilization a)General i.Hospitalization ii.Monitor as appropriate iii.Pain relief iv.Sedation as necessary Identify and treat precipitating factors e.g. anaemia, tachiarrhythmias

Acute Coronary Syndromes TREATMENT b)Drugs i.Antithrombotic Antiplatelet e.g.. Aspirin Anticoagulant e.g.. Heparin ii.Antianginal Nitrates β-Blockers Calcium Antagonists iii.Disease Modifying Drug Statins ACE Inhibitors

Acute Coronary Syndromes TREATMENT 2.Coronary Angiography Evaluate coronary anatomy Depending on clinical and anatomic findings an appropriate long term treatment is determined.

Acute Coronary Syndromes LONG TERM TREATMENT  Medical therapy  Coronary angioplasty  Coronary artery Bypass Graft surgery

Diffuse Disease MAHOMED

Right Coronary Artery Before PTCA After PTCA

Stenting LAD BEFORE STENT LAD AFTER STENT

Multi vessel disease: Surgery

Patent LIMA

Patent SVG

Thank you